reports
- Jean Danjou
ODDO : March down in double digit leads to a -6.3% decline in Q1 for S...
>Swiss watch exports: March down -16.1% leads to a Q1 at -6.3% y-o-y (luxury category also negative over the quarter at -2.8%) - - Over March 2024, exports amounted to CHF 2,002m down 16.1% y-o-y after -3.6% in February and +3.1% in January. This is a very weak figure but was obviously impacted to a good extent by a negative working days effect. On the whole, Q1 was down -6.3% (as a reminder: Q4 2023 witnessed +4.7% growth, FY 2023 growth ended at +7.6%). The l...
- Maissa Keskes
- Stephane Houri
EDEN EDENRED SA
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
BN DANONE SA
KPN ROYAL KPN NV
VOLV B VOLVO AB CLASS B
ABB ABB LTD.
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
REE RED ELECTRICA CORP. SA
ENI ENI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
CAP CAPGEMINI SE
EZJ EASYJET PLC
REP REPSOL SA
DIM SARTORIUS STEDIM BIOTECH SA
ACS ACTIVIDADES DE CONSTRUCCION Y SERVICIOS SA
BC BRUNELLO CUCINELLI S.P.A.
HLAG HAPAG-LLOYD AG
BHP BHP GROUP LTD
ASML ASML HOLDING NV
BP. BP P.L.C.
FDJ LA FRANCAISE DES JEUX SA
SHEL SHELL PLC
SGSN SGS SA
- Jean Danjou
ODDO : March down in double digit leads to a -6.3% decline in Q1 for S...
>Swiss watch exports: March down -16.1% leads to a Q1 at -6.3% y-o-y (luxury category also negative over the quarter at -2.8%) - - Over March 2024, exports amounted to CHF 2,002m down 16.1% y-o-y after -3.6% in February and +3.1% in January. This is a very weak figure but was obviously impacted to a good extent by a negative working days effect. On the whole, Q1 was down -6.3% (as a reminder: Q4 2023 witnessed +4.7% growth, FY 2023 growth ended at +7.6%). The l...
- Maissa Keskes
- Stephane Houri
EDEN EDENRED SA
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
BN DANONE SA
KPN ROYAL KPN NV
VOLV B VOLVO AB CLASS B
ABB ABB LTD.
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
REE RED ELECTRICA CORP. SA
ENI ENI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
CAP CAPGEMINI SE
EZJ EASYJET PLC
REP REPSOL SA
DIM SARTORIUS STEDIM BIOTECH SA
ACS ACTIVIDADES DE CONSTRUCCION Y SERVICIOS SA
BC BRUNELLO CUCINELLI S.P.A.
HLAG HAPAG-LLOYD AG
BHP BHP GROUP LTD
ASML ASML HOLDING NV
BP. BP P.L.C.
FDJ LA FRANCAISE DES JEUX SA
SHEL SHELL PLC
SGSN SGS SA
- Nicolas David
Capgemini : Set for lacklustre growth in Q1. The upturn will be notice...
>Towards a continued slowdown in Q1 2024: organic growth of -4%e - Capgemini is due to publish its Q1 2024 results on 30 April before the market open. In line with the company's message since the FY 2023 results release in February and given Accenture's mixed performance for its Q2 FY 2023-24 (quarter ended end of February 2024), we expect a significant deterioration in growth in Q1 (-4.0%) compared with Q4 (-0.9%), due to challenging base effects and weak demand on ...
- Nicolas David
Capgemini : Vers une croissance T1 en demi-teinte. La recovery sera su...
>Vers une poursuite du ralentissement au T1 2024 : croissance org de -4%e - Capgemini publiera son CA T1 2024 le 30 avril avant Bourse. Conformément au message de la société depuis la publication des résultats 2023 en février dernier et compte tenu de la performance mitigée d’Accenture pour son T2 FY 2024 (trimestre clos à fin février 2024), nous attendons une détérioration significative de la croissance au T1 (-4.0%) par rapport au T4 (-0.9%), en raison d’effets de ...
Solvay releases 2023 annual integrated report
Solvay releases 2023 annual integrated report The first annual report reflecting Solvay’s new scope highlights a year of resilience and sustainable progress Brussels, April 17, 2024 - 6:00 pm CEST - regulated information Solvay today released its annual integrated report, which provides an overview of the company’s economic, environmental, and societal performance for 2023. It details the Group’s financial and extra-financial progress, governance, remuneration and risk management practices. This comprehensive document serves as a reference point for stakeholders to understand the tr...
Solvay publie son rapport annuel intégré 2023
Solvay publie son rapport annuel intégré 2023 Le premier rapport annuel qui illustre le nouveau périmètre de Solvay met en évidence une année marquée par la résilience et le progrès durable Bruxelles, le 17 avril 2024 - 18h00 CEST - information réglementée Solvay publie son rapport annuel intégré, qui présente un bilan des performances économiques, environnementales et sociétales de l'entreprise pour l'année 2023. Il détaille les progrès financiers et extra-financiers du Groupe, ainsi que ses pratiques en matière de gouvernance, de rémunération et de gestion des risques. Ce document ...
- Emna Ben Bdira
- Maxime Kogge
Rio Tinto Plc : Decent Q1 production numbers in all divisions but copp...
>Good numbers in iron ore and aluminium, copper underwhelming again - Rio Tinto yesterday evening released solid Q4 production numbers, broadly in line with our forecasts, but copper remained underwhelming. In the core Iron Ore division (75% of 2024e EBITDA), production stood at 78mt, -2% y-o-y, and shipments at 77.9mt, -1% (both standing 1% > ODDO BHF), affected by planned depletion (ahead of the start-up of Western Range in 2025) but also weather disruptions at the ...
- Salome Charamalet
- Stefano Toffano
- Salome Charamalet
- Stefano Toffano
- Emna Ben Bdira
- Maxime Kogge
Rio Tinto Plc : Decent Q1 production numbers in all divisions but copp...
>Good numbers in iron ore and aluminium, copper underwhelming again - Rio Tinto yesterday evening released solid Q4 production numbers, broadly in line with our forecasts, but copper remained underwhelming. In the core Iron Ore division (75% of 2024e EBITDA), production stood at 78mt, -2% y-o-y, and shipments at 77.9mt, -1% (both standing 1% > ODDO BHF), affected by planned depletion (ahead of the start-up of Western Range in 2025) but also weather disruptions at the ...
- Ana Arjona-Martinez
- Yan Derocles
Aeroports de Paris : Good but not outstanding start of 2024
>Traffic growth continues in March, with International assets outperforming - ADP published its traffic figures for March yesterday, with total number of passengers at Paris reaching 8.0 million: +7.7% y-o-y or -8.1% vs 2019. Paris-CDG reported traffic growth of 6.6% y-o-y, reaching 90.5% of the 2019, a bit shy of our expectations. On the contrary, Paris-Orly reported traffic growth of +10.1% (-4.8% vs 2019), which was a positive after the weak data of previous month...
- Fehmi Ben Naamane
- Johanna Jourdain
Accor : Qu’attendre de la publication T1 24 ? (le 25/04 après Bourse)
>Tendances toujours solides au T1 : normalisation de la demande sur un niveau élevé au global et des upsides au MO et en ASPAC - Accor publiera son CA T1 24 le 25/04 après Bourse. Nous attendons un CA de 1 197 M€ (consensus 1 216 M€) porté par un nouveau trimestre de croissance solide des RevPAR, à +7.2%e (consensus +7.5%). Celle-ci repose sur la normalisation de la hausse des RevPAR sur un niveau low single digit en Europe, aux US et en Amérique du Sud, alors que les...
- Fehmi Ben Naamane
- Johanna Jourdain
Accor : What to expect from the Q1 2024 release? (25 April after tradi...
>Still solid trends in Q1: demand normalising at a high level overall and upside in ME and ASPAC - Accor is due to report its Q1 2024 revenues on 25 April after trading. We expect sales of € 1.197bn (consensus € 1.216bn), driven by another quarter of solid RevPAR growth, at +7.2%e (consensus +7.5%). This is based on a normalisation of RevPAR growth in low single digits in Europe, the US and South America, while the Middle East and ASPAC zones are seeing stronger grow...
Press Release: New 48-week frexalimab phase 2 data support potential f...
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a potential first-in-class, high-efficacy, non-lymphocyte depleting treatment for relapsing multiple sclerosis96% of participants receiving high-dose intravenous frexalimab had no new Gd+ T1 lesions and an annualized relapse rate of 0.04 after 48 weeksSanofi has initiated global phase 3 studies of frexalimab in relapsing MS and non-relapsing se...
Communiqué de presse : De nouveaux résultats de phase II à 48 semaines...
Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques Les données montrent que le frexalimab a le potentiel d’être le premier de sa classe pharmacothérapeutique pour le traitement de la sclérose en plaques récurrente-rémittente, en plus d’être hautement efficace et sans effet déplé...
Kering: Monthly statement on the total number of shares and voting rig...
Kering: Monthly statement on the total number of shares and voting rights (April 2024) KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS April 16, 2024 Monthly statementon the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) Date Total number ofshares Total number of voting rights theoretical 1 exercisab...
Kering : Publication mensuelle du nombre d’actions composant le capita...
Kering : Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote (Avril 2024) KeringSociété anonyme au capital de 493 683 112 €Siège social : 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS Le 16 avril 2024 Publication mensuelledu nombre d’actions composant le capital et du nombre total de droits de vote(articles L. 233-8 du code de commerce et 223-16 du règlement général de l’AMF) Date d’arrêt desInformations Nombre total d’actionscomposant le capital Nombre total de droits de vote théoriques 1 exerçables 2 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.